novo glp-1 Novo, Lilly buoyed by fast-growing drug sales Novo Nordisk promotes new GLP-1
Description
However, these discounts are not widespread, and affordability remains a significant challenge
14% with placebo, P = 0.46) [44]
Transporter-mediated endocytosis is a way of specifically targeting a transporter to facilitate cellular uptake of biological therapeutics [30,31,32,33]
Coverage for GLP-1s remains a key challenge for employers to navigate, as there is significant demand for the drugs that often come at a high cost
No signs of tampering
